Results 1 to 10 of about 275,589 (191)

Systemic Impact of Helicobacter pylori: A Cross‐Sectional Study [PDF]

open access: yesJGH Open
Background and Aim Helicobacter pylori is an oncobacteria that infects about half of the world's population and has a well‐established role in the etiology of gastric diseases.
Amanda Ferreira Paes Landim Ramos   +7 more
doaj   +2 more sources

The evolution of SARS-CoV-2 and the COVID-19 pandemic [PDF]

open access: yesPeerJ, 2023
Scientists have made great efforts to understand the evolution of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) to provide crucial information to public health experts on strategies to control this viral pathogen.
Yuanfang Si   +10 more
doaj   +2 more sources

Molecular docking of a set of flavonoid compounds with Helicobacter pylori virulence factors CagA and VacA [PDF]

open access: yesJournal of HerbMed Pharmacology, 2020
Introduction: Cytotoxin associated gene A (CagA) and vacuolating cytotoxin A (VacA) proteins are the main Helicobacter pylori virulence factors. These toxins are associated with severe gastric diseases.
Mohamed Reda Jouimyi   +7 more
doaj   +1 more source

Association of Helicobacter pylori vacA polymorphisms with the risk of gastric precancerous lesions in a Moroccan population

open access: yesJournal of Infection in Developing Countries, 2021
Introduction: Helicobacter pylori infection is the major risk factor of atrophic gastritis and intestinal metaplasia. The vacA gene is one of the most virulence factors of H.
Mohamed Reda Jouimyi   +9 more
doaj   +1 more source

Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment

open access: yesFrontiers in Genetics, 2022
Gastric cancer (GC) is a highly fatal and common malignancy of the digestive system. Recent therapeutic advancements have significantly improved the clinical outcomes in GC, but due to the unavailability of suitable molecular targets, a large number of ...
Fazhan Li   +17 more
doaj   +1 more source

Armeniaspirol A: a novel anti‐Helicobacter pylori agent

open access: yesMicrobial Biotechnology, 2022
Summary Antibiotic resistance in Helicobacter pylori has been growing worldwide with current treatment regimens. Development of new compounds for treatment of H.
Jia Jia   +8 more
doaj   +1 more source

The impact of dioctyl phthalate exposure on multiple organ systems and gut microbiota in mice

open access: yesHeliyon, 2023
Dioctyl phthalate, commonly known as bis(2-ethylhexyl) phthalate (DEHP), is a widely used plasticizer in various industries and has been shown to directly or indirectly impact human health. However, there is a lack of comprehensive studies evaluating the
Qiang Zhang   +7 more
doaj   +1 more source

A study on the diagnosis of the Helicobacter pylori coccoid form with artificial intelligence technology

open access: yesFrontiers in Microbiology, 2022
BackgroundHelicobacter pylori (H. pylori) is an important pathogenic microorganism that causes gastric cancer, peptic ulcers and dyspepsia, and infects more than half of the world’s population. Eradicating H. pylori is the most effective means to prevent
Zishao Zhong   +17 more
doaj   +1 more source

Clinical implications of lncRNA LINC-PINT in cancer

open access: yesFrontiers in Molecular Biosciences, 2023
Long noncoding RNAs (lncRNAs) possess the potential for therapeutic targeting to treat many disorders, including cancers. Several RNA-based therapeutics (ASOs and small interfering RNAs) have gained FDA approval over the past decade.
Ihtisham Bukhari   +6 more
doaj   +1 more source

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice

open access: yesFrontiers in Nutrition, 2023
Background/aimsSome studies showed that probiotics could improve the composition and structure of gut microbiota. Changes in the gut microbiota may alter bile acid (BAs) composition and kinetics, improving non-alcoholic fatty liver disease (NAFLD ...
Minghua Yang   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy